Altered HDL subclasses in endogenous hypertriglyceridemia are not affected by weight reduction

Area of Science:

• Metabolic research
• Lipidology
• Cardiovascular disease research

Background:

• Body weight reduction is a common strategy for managing hypertriglyceridemia.
• The impact of sustained weight loss on lipoprotein composition and structure remains incompletely understood.
• Lipoprotein structure is critical in lipid metabolism and the development of atherosclerosis.

Purpose of the Study:

• To investigate the effects of stabilized weight reduction on plasma lipoprotein concentrations, compositions, and ultracentrifugal properties.
• To assess changes in lipoprotein structure and distribution in patients with endogenous hypertriglyceridemia and low high-density lipoprotein (HDL)-cholesterol.

Main Methods:

• Nine patients with endogenous hypertriglyceridemia and low HDL-cholesterol underwent two dietary periods: basal (isocaloric) and low-weight (hypocaloric).
• Weight was reduced (9.6 +/- 3.6 kg) over 16-52 weeks, followed by a 5-week weight maintenance period.
• Plasma samples were analyzed for lipoprotein concentrations, compositions, and ultracentrifugal flotation properties during stable high and low body weight phases.

Main Results:

• Fasting plasma total triglycerides decreased significantly (from 328 +/- 204 mg/dL to 185 +/- 77 mg/dL, P < 0.01) after weight reduction.
• Stabilized weight loss led to notable alterations in lipoprotein concentrations, compositions, and ultracentrifugal properties.
• Specific changes in lipoprotein subclasses and their atherogenic potential were observed, though not detailed in the truncated abstract.

Conclusions:

• Stabilized weight reduction is effective in decreasing plasma triglyceride levels in patients with endogenous hypertriglyceridemia.
• Weight loss influences the composition and structure of lipoproteins, which may have implications for cardiovascular risk.
• Further research is warranted to fully elucidate the atherogenic implications of weight-loss-induced lipoprotein modifications.